Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat
Cibus (NASDAQ: CBUS), an agricultural biotechnology company specializing in proprietary gene editing technologies for seed trait development, has made available a replay of its participation in the BofA Securities 2025 AgTech Virtual Conference. During the fireside chat, Co-Founder, President and Interim CEO Peter Beetham discussed with BofA analyst Stephen Byrne three key areas: the company's unique gene editing platform, progress in their productivity trait pipeline toward commercial goals, and the impact of recent regulatory changes supporting agricultural innovation globally. The webcast recording can be accessed through Cibus's investor relations website.
Cibus (NASDAQ: CBUS), un'azienda di biotecnologie agricole specializzata in tecnologie proprietarie di editing genetico per lo sviluppo di caratteristiche delle sementi, ha reso disponibile la registrazione della sua partecipazione alla BofA Securities 2025 AgTech Virtual Conference. Durante la tavola rotonda, il cofondatore, presidente e CEO ad interim Peter Beetham ha discusso con l'analista di BofA Stephen Byrne tre temi principali: la piattaforma unica di editing genetico dell'azienda, i progressi nella pipeline di caratteristiche per la produttività verso gli obiettivi commerciali e l'impatto delle recenti modifiche normative a sostegno dell'innovazione agricola a livello globale. La registrazione del webcast è accessibile tramite il sito web delle relazioni con gli investitori di Cibus.
Cibus (NASDAQ: CBUS), una empresa de biotecnología agrícola especializada en tecnologías propietarias de edición genética para el desarrollo de características en semillas, ha puesto a disposición la grabación de su participación en la Conferencia Virtual AgTech 2025 de BofA Securities. Durante el diálogo, el cofundador, presidente y CEO interino Peter Beetham conversó con el analista de BofA Stephen Byrne sobre tres temas clave: la plataforma única de edición genética de la compañía, el progreso en su pipeline de características de productividad hacia objetivos comerciales, y el impacto de los recientes cambios regulatorios que apoyan la innovación agrícola a nivel global. La grabación del webcast está disponible en el sitio web de relaciones con inversionistas de Cibus.
Cibus (NASDAQ: CBUS)는 종자 특성 개발을 위한 독자적인 유전자 편집 기술을 전문으로 하는 농업 생명공학 회사로, BofA Securities 2025 AgTech 가상 컨퍼런스 참여 녹화 영상을 제공하고 있습니다. 대담에서 공동 창립자이자 사장 겸 임시 CEO인 Peter Beetham은 BofA 애널리스트 Stephen Byrne과 함께 회사의 독특한 유전자 편집 플랫폼, 상업적 목표를 향한 생산성 특성 파이프라인의 진전, 그리고 전 세계 농업 혁신을 지원하는 최근 규제 변화의 영향 등 세 가지 핵심 주제를 논의했습니다. 웹캐스트 녹화 영상은 Cibus 투자자 관계 웹사이트를 통해 접속할 수 있습니다.
Cibus (NASDAQ : CBUS), une entreprise de biotechnologie agricole spécialisée dans les technologies propriétaires d'édition génétique pour le développement de traits semenciers, a rendu disponible la rediffusion de sa participation à la Conférence virtuelle AgTech 2025 de BofA Securities. Lors de la discussion informelle, le cofondateur, président et CEO par intérim Peter Beetham a échangé avec l'analyste de BofA Stephen Byrne sur trois points clés : la plateforme unique d'édition génétique de l'entreprise, les progrès de leur pipeline de traits de productivité en vue des objectifs commerciaux, et l'impact des récents changements réglementaires favorisant l'innovation agricole à l'échelle mondiale. L'enregistrement du webcast est accessible via le site des relations investisseurs de Cibus.
Cibus (NASDAQ: CBUS), ein Unternehmen für Agrarbiotechnologie, das sich auf proprietäre Gen-Editing-Technologien zur Entwicklung von Saatgutmerkmalen spezialisiert hat, stellt eine Aufzeichnung seiner Teilnahme an der BofA Securities 2025 AgTech Virtual Conference zur Verfügung. Während des Gesprächs diskutierten Mitgründer, Präsident und Interim-CEO Peter Beetham und BofA-Analyst Stephen Byrne drei zentrale Themen: die einzigartige Gen-Editing-Plattform des Unternehmens, Fortschritte in der Pipeline für Produktivitätsmerkmale auf dem Weg zu kommerziellen Zielen und die Auswirkungen jüngster regulatorischer Änderungen zur Unterstützung landwirtschaftlicher Innovationen weltweit. Die Webcast-Aufzeichnung ist über die Investor-Relations-Website von Cibus zugänglich.
- None.
- None.
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Peter Beetham, Co-Founder, President and Interim Chief Executive Officer, participated in the BofA Securities 2025 AgTech Virtual Conference this week.
During the fireside chat, hosted by BofA research analyst Stephen Byrne, management discussed the Company's differentiated gene editing platform, the progression of its productivity trait pipeline towards commercial milestones and how the advancements in recent regulatory developments are supporting agricultural innovation in global markets.
The webcast is now available for replay in the events section of the Company's investor relations website at https://investor.cibus.com/events.
About Cibus
Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately
CIBUS CONTACTS:
INVESTOR RELATIONS
Karen Troeber
ktroeber@cibus.com
858-450-2636
Jeff Sonnek – ICR
jeff.sonnek@icrinc.com
MEDIA RELATIONS
Colin Sanford
colin@bioscribe.com
203-918-4347
FAQ
What topics did Cibus (CBUS) discuss at the BofA Securities 2025 AgTech Conference?
Who represented Cibus at the BofA Securities 2025 AgTech Conference?
Where can investors access the replay of Cibus's BofA Securities conference presentation?
What is Cibus's (CBUS) main business focus?
